Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790075 | Urologic Oncology: Seminars and Original Investigations | 2018 | 6 Pages |
Abstract
Knowledge of TGP in RP specimens is likely to improve risk stratification, patient counseling and follow-up scheduling. Further prospective studies that control significant clinical endpoints such as metastasis and mortality are necessary for more significant predictions.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mehmet M.D., David M.D., Marco M.D., Ph.D., Beat M.D., Mohammad M.D., Romain M.D., Alberto M.D., Ph.D., Pierre I. M.D., Morgan M.D., Christian M.D., Anna Katarzyna M.D., Martin M.D., Shahrokh F. M.D.,